by Kayt Sukel
Discovery that the fluid between brain cells acts as sewer lines while we sleep has some researchers theorizing that we might find biomarkers that could predict diseases at a much earlier stage.By Craig Stark, PhD
by Jim Schnabel
Our constant exposure to over-inflated claims of what technologies like neuroimaging can do are leading to a form of collective false memory in the form of an unreasonable expectation of what the technology can prove. One of our series of Reports on Progress
by Kayt Sukel
Researchers, doctors, and patients
await the results of the first clinical trial to prevent Alzheimer’s in
ordinary elderly people.
Learning false information when sleepy can change a person’s memory of a photograph, researchers find.by Jim Schnabel
new insights into how the tau protein spreads within and harms the brain, in
Alzheimer’s and other diseases--and tau-targeting therapies are now entering
clinical trials.by Guy McKhann, MD
Recipients of a Lasker Award this year, Alim Louis Benabid and Mahlon DeLong are the epitome of clinical scientists, going from the patient to the laboratory and back to the patient. Clinical scientists just getting started in their careers can learn from them. From our free print publication, Brain in the News.AAAS Capitol Hill Briefing
As autism prevalence rises, early behavioral intervention is key, experts say, and insights on brain signaling could lead to new treatments. A report from a Capitol Hill briefing in July. See also links to video of the briefing.Brenda Patoine
Most drug development for depression has focused on undoing the bad effects of stress, but new research suggests that finding ways to induce resilience could lead to new treatments. One of our series of Briefing Papers.